Asia Pacific Epithelial Cell Culture Media Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type and End User

The renal epithelial cell segment by product type is estimated to lead the market growth during the forecast period.

According to a new market research study of “Asia Pacific Epithelial Cell Culture Media Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product Type, End-user and Country.” The Asia Pacific epithelial cell culture media market is expected to reach US$ 71,089.17 thousand by 2028 from US$ 31,930.67 thousand in 2021; it is estimated to grow at a CAGR of 12.1% from 2021 to 2028. The report highlights trends prevailing in the Asia Pacific epithelial cell culture media market and the factors driving market along with those that act as hindrances.

The Asia Pacific epithelial cell culture media market, by product type, is segmented human mammary epithelial cells, bronchia/trachea epithelial cells, renal epithelial cells, and others. The bronchia/trachea epithelial cells segment held the largest share of the market in 2020, whereas the renal epithelial cell segment is anticipated to register the highest CAGR in the market during the forecast period.

Epithelial cells are valuable in biology research to understand the function of living systems. Rapid advancements in the biopharmaceuticals industry are allowing a better understanding of diseases at molecular level. The biopharmaceuticals industry in Singapore has expanded enormously over the past few decades, and it marks the presence of more than 120 biotechnology companies as of 2020. Epithelial cell cultures are widely used in biopharmaceutical and biotechnology industry for drug discovery, drug transport, drug screening and other applications. Thus, the huge presence and vigorous activities in biopharmaceuticals industries in different countries is creating opportunities for research and innovation, further attracting numerous public-private investments, which are creating significant growth opportunities for the epithelial cell culture media market players. In the last decade of the century, the tissue engineering techniques have emerged impressively, and they are now being employed in broader areas of regenerative medicine. Further, the regenerative medicines, developed using cell-based models, can potentially assist researchers in early-intervention of degenerative diseases and traumatic injuries. Thus, growing focus on bringing advancements in regenerative medicine is likely to boost the adoption of epithelial cells cultures, thereby bolstering the demand for the respective culture media in the coming years.

Asia Pacific region is highly affected due to the outbreak of the COVID-19 pandemic. The COVID-19 pandemic has negatively impacted all phases of drug development and forced many pharmaceutical companies and clinical research organizations (CROs) to put their clinical studies on hold. Moreover, the ongoing COVID-19 crisis is likely to put additional pressure on the market to meet the future demand for cell and gene therapies. However, an increase in the number of biotech incubators across Asia Pacific stimulates research and encourage start-up growth, which is crucial for the biotech industry's success. Hence, such outbreaks continue the need for new technologically advanced products nationwide, thereby positively impacting the market.

The growth of the market is attributed to some key driving factors such as prospering biopharmaceuticals industries in different countries and rising adoption of regenerative medicines. However, risk of contamination, misidentification, and random alternations in cell lines is expected to obstruct the growth of the market to a certain extent during the forecast years.

Thermo Fisher Scientific Inc. PromoCell GmbH, MERCK KGaA, ATCC, Lonza, HiMedia Laboratories, and BIO-TECHNE CORPORATION are among the leading companies operating in the Asia Pacific epithelial cell culture media market.

The report segments in Asia Pacific Epithelial Cell Culture Media Market as follows:

By Product Type

• Human Mammary Epithelial Cells
• Bronchia/Trachea Epithelial Cells
• Renal Epithelial Cells
• Others

By End-user

• Biopharmaceutical Companies
• Academic and Research Laboratories
• Others

By Country

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Reasons to buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific epithelial cell culture media market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific epithelial cell culture media market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution